RESUMEN
BACKGROUND: Naproxen is a non-steroidal anti-inflammatory drug (NSAID), belonging to propionic acid group, and its chemical structure is a 6-metoxi-metil-2-naftalenoacetic acid. Fixed drug eruptions (FDE) have been rarely reported. OBJECTIVE: A 38-year-old woman referred that after 2 hours of taking 2 tablets of naproxen for a headache, she developed several edematous and dusky-red macules, one on right forearm and the other two in both thighs and she was diagnosed with FDE probably due to naproxen. METHODS: We performed patch testing (PT) (Nonweven Patch Test Strips Curatest® Lohman & Rauscher International, Rangsdorf, Germany), with ibuprofen (5% Petrolatum), ketoprofen (2.5% Petrolatum), naproxen and nabumetone (both 10% in DMSO) on the residual lesion of the forearm with naproxen and in both thighs with ibuprofen, ketoprofen and nabumetone. RESULTS: Readings at day 1 (D1) and day 2 (D2) showed negative results to ibuprofen, ketoprofen and nabumetone, but were positive to naproxen in D1. A single blind oral challenge test (SBOCT) with other propionic acid derivates were performed in order to check for crossreactivity between them: ibuprofen, ketoprofen and nabumetone were administered and all drugs were well tolerated. CONCLUSION: In our patient PT confirmed the diagnosis and allowed us to study the cross-reactivity between NSAIDs of the same group, and confirmed by SBOCT. Cross-reactivity between propionic acid derivatives was studied. This is a case of hypersensitivity to naproxen with good tolerance to other propionic acids NSAIDs (ibuprofen and ketoprofen) and nabumetone, confirmed by PT and SBOCT. Some relavent patents for fixed drug eruption are discussed.
Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Erupciones por Medicamentos/etiología , Cefalea/tratamiento farmacológico , Naproxeno/efectos adversos , Adulto , Reacciones Cruzadas , Erupciones por Medicamentos/diagnóstico , Femenino , Humanos , Pruebas del Parche , Patentes como Asunto , Valor Predictivo de las PruebasRESUMEN
Wheat-dependent exercise-induced anaphylaxis (WDEIA) is increasing. In vitro test such as omega-5-gliadin levels are useful in the diagnosis, while oral single blind challenge tests (OCT) with wheat plus exercise continuous being the gold standard diagnostic method. This paper reports the case of a 38-year-old woman, with several episodes of anaphylaxis after eating different foods and doing exercise after ingestion. An allergy study was performed with positive skin prick tests for wheat, barley and rye. Total IgE 238.0KU/L, positive specific IgE (>100KU/L) to wheat, barley and rye, and negative to rTri-a-19 omega-5 gliadin. OCT with bread and exercise was positive. In this case of wheat-dependent exerciseinduced anaphylaxis (WDEIA) with negative serum specific IgE to omega-5-gliadin, negative results with gamma, alpha, bheta y omega-gliadin doesn't exclude the diagnosis of WDEIA.
La anafilaxia inducida por ejercicio dependiente de trigo (WDEIA por sus siglas en inglés de wheat-dependent-exercise-induced-anaphylaxis) es una entidad cada vez más frecuente. La detección de IgE frente a omega-5-gliadina in vitro se usa como método diagnóstico, pero la provocación oral controlada simple ciego (POC) con el alimento, junto con la realización de ejercicio físico, es el método diagnóstico patrón de referencia. Se comunica el caso de una paciente de 38 años de edad, con antecedente de episodios de anafilaxia relacionados con la ingestión de alimentos y la realización de actividad física. Se realizó un estudio alergológico. Las pruebas cutáneas fueron positivas a harina de trigo, cebada y centeno. IgE total: 238.0 kU/L, IgE específica positiva (mayor de 100 kU/L) a trigo, cebada, centeno y negativa a rTri-a-19omega-5 gliadina. La provocación oral controlada con pan de trigo y ejercicio físico fue positiva. En este caso con anafilaxia inducida por ejercicio dependiente de trigo sin sensibilización omega-5 gliadina la ausencia de IgE frente gamma, alfa, beta yï omega-gliadina no excluiría el diagnóstico de esta enfermedad.
Asunto(s)
Anafilaxia/etiología , Grano Comestible/efectos adversos , Ejercicio Físico , Hipersensibilidad al Trigo/complicaciones , Adulto , Alérgenos , Antígenos de Plantas/inmunología , Grano Comestible/inmunología , Femenino , Gliadina/inmunología , Humanos , Inmunoglobulina E/sangre , Método Simple Ciego , Pruebas Cutáneas , Hipersensibilidad al Trigo/diagnóstico , Hipersensibilidad al Trigo/inmunologíaAsunto(s)
Angioedema/inducido químicamente , Cerumenolíticos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Párpados , Adulto , Angioedema/diagnóstico , Angioedema/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Clorfeniramina/uso terapéutico , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Alérgica por Contacto/tratamiento farmacológico , Femenino , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Metilprednisolona/uso terapéutico , Pruebas del ParcheAsunto(s)
Pustulosis Exantematosa Generalizada Aguda/etiología , Nitroimidazoles/efectos adversos , Pustulosis Exantematosa Generalizada Aguda/diagnóstico , Pustulosis Exantematosa Generalizada Aguda/tratamiento farmacológico , Adulto , Glucocorticoides/administración & dosificación , Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Humanos , Inyecciones Intramusculares , Masculino , Pruebas del Parche , Valor Predictivo de las Pruebas , Resultado del TratamientoAsunto(s)
Antibacterianos/efectos adversos , Hipersensibilidad a las Drogas/etiología , Imipenem/efectos adversos , Linfocitos T/efectos de los fármacos , Tienamicinas/efectos adversos , Anciano , Antibacterianos/química , Antibacterianos/inmunología , Reacciones Cruzadas , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/inmunología , Femenino , Humanos , Imipenem/química , Imipenem/inmunología , Masculino , Meropenem , Persona de Mediana Edad , Estructura Molecular , Pruebas del Parche , Valor Predictivo de las Pruebas , Relación Estructura-Actividad , Linfocitos T/inmunología , Tienamicinas/química , Tienamicinas/inmunologíaRESUMEN
Esparto is a gramineous plant that has multiple applications in today's industry. Several cases of hypersensitivity pneumonitis (HP) caused by esparto inhalation have been reported, but only one case of asthma caused by Aspergillus fumigatus contaminating esparto has been communicated. We report a case of asthma induced by esparto inhalation in a 58-year-old man, who is a building industry worker, with subclinical sensitization to grass pollen. The relation between clinical symptoms and work activities was supported by peak expiratory flow (PEF) monitorization; PEF values decreased by 20% the days he handled esparto. Prick test with esparto was positive. Immunoblot analysis revealed several allergens in the esparto extract, some of them present in Lolium and A. fumigatus extracts. IgE immunoblot inhibition revealed a complete inhibition of lolium and A. fumigatus IgE reactive bands by esparto proteins. The patient then avoided the exposure to esparto at work and has remained asymptomatic for the last 2 years. In conclusion, this is a case of occupational asthma caused by esparto dust mediated by IgE antibodies. Proteins of A. fumigatus as well as proteins from this gramineous plant, which cross-reacted with esparto allergens, were responsible for the disease.